QUANTGENE Trademark

Trademark Overview

On Monday, December 9, 2019, a trademark application was filed for QUANTGENE with the United States Patent and Trademark Office. The USPTO has given the QUANTGENE trademark a serial number of 88720359. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Monday, December 27, 2021. This trademark is owned by Quantgene Inc.. The QUANTGENE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Diagnostic testing services, namely, medical diagnostic testing for cancer and other diseases and disorders; medical testing for diagnostic or treatment purposes; providing cancer screening services
quantgene

General Information

Serial Number88720359
Word MarkQUANTGENE
Filing DateMonday, December 9, 2019
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateMonday, December 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkQUANT GENE
Goods and ServicesDiagnostic testing services, namely, medical diagnostic testing for cancer and other diseases and disorders; medical testing for diagnostic or treatment purposes; providing cancer screening services

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 12, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQuantgene Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90404

Trademark Events

Event DateEvent Description
Wednesday, October 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 3, 2022ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Monday, December 27, 2021ABANDONMENT - AFTER EX PARTE APPEAL
Monday, December 27, 2021EXPARTE APPEAL TERMINATED
Tuesday, October 12, 2021EX PARTE APPEAL-REFUSAL AFFIRMED
Monday, July 26, 2021NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Monday, July 26, 2021EXAMINERS STATEMENT E-MAILED
Monday, July 26, 2021EXAMINERS STATEMENT - COMPLETED
Thursday, July 1, 2021ASSIGNED TO EXAMINER
Tuesday, June 22, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, April 19, 2021NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Monday, April 19, 2021ACTION DENYING REQ FOR RECON E-MAILED
Monday, April 19, 2021ACTION CONTINUING FINAL - COMPLETED
Wednesday, April 7, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 7, 2021EX PARTE APPEAL-INSTITUTED
Wednesday, April 7, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, April 7, 2021EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, October 7, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 7, 2020FINAL REFUSAL E-MAILED
Wednesday, October 7, 2020FINAL REFUSAL WRITTEN
Saturday, September 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 13, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 13, 2020NON-FINAL ACTION E-MAILED
Friday, March 13, 2020NON-FINAL ACTION WRITTEN
Monday, March 9, 2020ASSIGNED TO EXAMINER
Thursday, December 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 12, 2019NEW APPLICATION ENTERED

Related Keywords

quantgene diagnostic testing cancer medical services purposes providing treatment screening other